نتایج جستجو برای: cytogenetic risk groups

تعداد نتایج: 1591243  

Journal: :international journal of hematology-oncology and stem cell research 0
farhad zaker nahid nasiri naser amirizadeh seyed mohsen razavi marjan yaghmaie ladan teimoori-toolabi

objectives: myelodysplastic syndromes (mdss) include a diverse group of clonal bone marrow disorders characterized by ineffective hematopoiesis and pancytopenia. it was found that down regulation of apaf1 , a putative tumor suppressor gene, leads to resistance to chemotherapy and disease development in some cancers. in this study, we investigated the relation of apaf1 methylation status with it...

Journal: :Haematologica 2014
Marjolein Blink Martin Zimmermann Christine von Neuhoff Dirk Reinhardt Valerie de Haas Henrik Hasle Maureen M O'Brien Batia Stark Julie Tandonnet Andrea Pession Katerina Tousovska Daniel K L Cheuk Kazuko Kudo Takashi Taga Jeffrey E Rubnitz Iren Haltrich Walentyna Balwierz Rob Pieters Erik Forestier Bertil Johansson Marry M van den Heuvel-Eibrink C Michel Zwaan

Myeloid leukemia of Down syndrome has a better prognosis than sporadic pediatric acute myeloid leukemia. Most cases of myeloid leukemia of Down syndrome are characterized by additional cytogenetic changes besides the constitutional trisomy 21, but their potential prognostic impact is not known. We, therefore, conducted an international retrospective study of clinical characteristics, cytogeneti...

Journal: :Современные проблемы науки и образования (Modern Problems of Science and Education) 2020

Journal: :Blood 2006
Lydia Roy Joëlle Guilhot Tillmann Krahnke Agnès Guerci-Bresler Brian J Druker Richard A Larson Steve O'Brien Charlene So Giorgio Massimini François Guilhot

In the multinational IRIS study comparing imatinib with interferon plus cytarabine (IFN/Ara-C) in patients with newly diagnosed chronic-phase chronic myelogenous leukemia (CP CML), imatinib demonstrated significantly higher rates of complete cytogenetic responses (CCyRs) and improved progression-free survival (PFS). However, because of a high early crossover rate to imatinib, survival benefit w...

Journal: :Fetal diagnosis and therapy 2008
Anna Soler Carme Morales Cèlia Badenas Laia Rodríguez-Revenga Ana Carrió Ester Margarit Dolors Costa Antoni Borrell Anna Goncé Montserrat Milà Aurora Sánchez

OBJECTIVES To report our experience over the past 10 years of chorionic villi sampling (CVS) prenatal diagnosis in a high-risk population for chromosomal anomalies, and to analyze, according to the results, the advantages and disadvantages of using quantitative fluorescence polymerase chain reaction (QF-PCR) in amniotic fluid with respect to a conventional semi-direct cytogenetic CVS method in ...

Journal: :Genetics 2002
Elaine C Howell Guy C Barker Gareth H Jones Michael J Kearsey Graham J King Erik P Kop Carol D Ryder Graham R Teakle Joana G Vicente Susan J Armstrong

We have assigned all nine linkage groups of a Brassica oleracea genetic map to each of the nine chromosomes of the karyotype derived from mitotic metaphase spreads of the B. oleracea var. alboglabra line A12DHd using FISH. The majority of probes were BACs, with A12DHd DNA inserts, which give clear, reliable FISH signals. We have added nine markers to the existing integrated linkage map, distrib...

2012
Gonzalo Guevara Jaime A González Diego E Lopera Manuel González José D Saavedra José Fernando Lobaton Jorge Enrique Duque

OBJECTIVE To evaluate the hematological, cytogenetic, and molecular responses in Colombian patients with CML chronic myeloid leukemia (CML) treated with imatinib. METHODS Two groups of patients, one with the novo diagnostic and another in state of complete cytogenetic remission were followed for 12 months with quantitative PCR evaluations every three months and with chromosomal analysis every...

Journal: :Blood 2009
Francisco Cervantes Brigitte Dupriez Arturo Pereira Francesco Passamonti John T Reilly Enrica Morra Alessandro M Vannucchi Ruben A Mesa Jean-Loup Demory Giovanni Barosi Elisa Rumi Ayalew Tefferi

Therapeutic decision-making in primary myelofibrosis (PMF) is becoming more challenging because of the increasing use of allogeneic stem cell transplantation and new investigational drugs. To enhance this process by developing a highly discriminative prognostic system, 1054 patients consecutively diagnosed with PMF at 7 centers were studied. Overall median survival was 69 months (95% confidence...

Journal: :Blood 2016
Hervé Avet-Loiseau Rafael Fonseca David Siegel Meletios A Dimopoulos Ivan Špička Tamás Masszi Roman Hájek Laura Rosiñol Vesselina Goranova-Marinova Georgi Mihaylov Vladimír Maisnar Maria-Victoria Mateos Michael Wang Ruben Niesvizky Albert Oriol Andrzej Jakubowiak Jiri Minarik Antonio Palumbo William Bensinger Vishal Kukreti Dina Ben-Yehuda A Keith Stewart Mihaela Obreja Philippe Moreau

The presence of certain high-risk cytogenetic abnormalities, such as translocations (4;14) and (14;16) and deletion (17p), are known to have a negative impact on survival in multiple myeloma (MM). The phase 3 study ASPIRE (N = 792) demonstrated that progression-free survival (PFS) was significantly improved with carfilzomib, lenalidomide, and dexamethasone (KRd), compared with lenalidomide and ...

Journal: :Environmental Health Perspectives 1991
W A Anwar

Somatic mutation plays a critical role in carcinogenesis. Numerous environmental agents can increase the probability that somatic mutation will occur. The use of genotoxicity testing is essential for assessing potential human toxicity so that hazards can be prevented. Cytogenetic monitoring of human populations exposed to chemicals has proved to be a useful tool for detecting the chemical mutag...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید